BIOEXTRAX AB (85X0) — Working Capital to Net Assets Ratio
BIOEXTRAX AB (85X0) has a Working Capital to Net Assets ratio of 66.6% as of March 2026. Working capital of €11.25 Million (current assets of €13.37 Million minus current liabilities of €2.11 Million) is measured against net assets of €16.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see BIOEXTRAX AB total assets.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BIOEXTRAX AB Working Capital to Net Assets (2021–2025)
This chart shows how BIOEXTRAX AB's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 66.6%, reflecting working capital of €11.25 Million against net assets of €16.89 Million EUR. Explore 85X0 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for BIOEXTRAX AB (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BIOEXTRAX AB from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read debt load of BIOEXTRAX AB for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.6% | €2.03 Million | €21.21 Million | €5.54 Million | €3.51 Million | ▼ -52.8 pp |
| 2024 | 62.4% | €16.26 Million | €26.06 Million | €19.20 Million | €2.94 Million | ▲ +0.2 pp |
| 2023 | 62.2% | €12.78 Million | €20.54 Million | €14.76 Million | €1.98 Million | ▼ -14.1 pp |
| 2022 | 76.3% | €24.25 Million | €31.77 Million | €30.40 Million | €6.15 Million | ▼ -7.4 pp |
| 2021 | 83.7% | €6.28 Million | €7.50 Million | €11.42 Million | €5.14 Million | — |